Skip to content

Efficacy of Sharkarayukta Bhunimba kalka and tab doxinate in Garbhini Chardi

An Open Randomised Controlled Clinical Trial to evaluate the efficacy of Sharkarayukta Bhunimba kalka in Garbhini Chardi with special reference to Emesis Gravidarum - NIL

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/0101868
Enrollment
80
Registered
2026-01-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O219- Vomiting of pregnancy, unspecified

Interventions

None listed

Sponsors

Dr Sangeeta Savalaram Chaudhary
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. ANC having Garbhini Chardi in first trimester of pregnancy of any gravida 2. ANC Patients having Normal ANC profile

Exclusion criteria

Exclusion criteria: 1. Garbhini having hyper emesis gravidarum 2. Garbhini with severe infection like TORCH,etc 3. Garbhini with systemic disorders like DM,Hypertension,etc 4. Garbhini on other medication causing nausea and vomiting

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Sharkarayukta Bhunimba Kalka in management of Garbhini Chardi with special reference to Emesis GravidarumTimepoint: 1st visit- Baseline 2nd visit- 3rd day 3rd visit-7th day 4th visit-15th day

Secondary

MeasureTime frame
To study & review literatue on Garbhini Chardi & emesis gravidarumTimepoint: 1st visit- Baseline 2nd visit- 3rd day 3rd visit-7th day 4th visit-15th day

Countries

India

Contacts

Public ContactDR SANGEETA SAVALARAM CHAUDHARY

Dr G D Pol Foundation YMT Ayurvedic Medical College and Hospital

pranalibhardwaj@gmail.com9619020010

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026